PHARMACOECONOMIC EVALUATION OF THE INTRODUCTION OF ROUTINE VARICELLA VACCINATION IN CHILDREN IN THE UNITED KINGDOM

被引：1
|
作者：
Holl, K. [1 ]
Hunjan, M. [2 ]
Sauboin, C. [1 ]
机构：
[1] GSK Vaccines, Wavre, Belgium
[2] GSK UK, Uxbridge, Middx, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1954
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN44
引用
收藏
页码：A583 / A583
页数：1
相关论文
共 50 条
  • [31] Postexposure varicella vaccination in siblings of children with: Active varicella
    Salzman, MB
    Garcia, C
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (03) : 256 - 257
  • [32] Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination
    Betta, Monica
    Laurino, Marco
    Pugliese, Andrea
    Guzzetta, Giorgio
    Landi, Alberto
    Manfredi, Piero
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2016, 283 (1826)
  • [33] Impact of a Routine Two-Dose Varicella Vaccination Program on Varicella Epidemiology
    Bialek, Stephanie R.
    Perella, Dana
    Zhang, John
    Mascola, Laurene
    Viner, Kendra
    Jackson, Christina
    Lopez, Adriana S.
    Watson, Barbara
    Civen, Rachel
    PEDIATRICS, 2013, 132 (05) : E1134 - E1140
  • [34] Vaccine Coverage and Acceptability of Varicella Vaccination in Children in the Munich Area after the Introduction of general Vaccination Recommendation
    Streng, A.
    Seeger, K.
    Grote, V
    Liese, J.
    KLINISCHE PADIATRIE, 2010, 222 : S55 - S55
  • [35] Pharmacoeconomic evaluation of flumazenil for routine outpatient esophagogastroduodenoscopy
    Wille, RT
    Chaffee, BW
    Walter, V
    Elta, GH
    Barnett, JL
    GASTROINTESTINAL ENDOSCOPY, 1997, 45 (04) : 134 - 134
  • [36] Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom Reply to Pawaskar et al.
    Akpo, E. I. Herve
    Cristeau, Olivier
    Hunjan, Manjit
    Casabona, Giacomo
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (05) : 936 - 937
  • [37] A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom
    Buller, N
    Gillen, D
    Casciano, R
    Doyle, J
    Wilson, K
    PHARMACOECONOMICS, 2003, 21 (Suppl 1) : 25 - 32
  • [38] A Pharmacoeconomic Evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study in the United Kingdom
    Nigel Buller
    David Gillen
    Roman Casciano
    John Doyle
    Koo Wilson
    PharmacoEconomics, 2003, 21 : 25 - 32
  • [39] Pharmacoeconomic evaluation of flumazenil for routine outpatient EGD
    Wille, RT
    Chaffee, BW
    Ryan, ML
    Elta, GH
    Walter, V
    Barnett, JL
    GASTROINTESTINAL ENDOSCOPY, 2000, 51 (03) : 282 - 287
  • [40] A cost benefit analysis of routine varicella vaccination in Spain
    Domingo, JD
    Ridao, M
    Latour, J
    Ballester, A
    Morant, A
    VACCINE, 1999, 17 (11-12) : 1306 - 1311
12345